C
Coloplast
Coloplast A/S Denmark, the Danish subsidiary, which markets and sells health care products in Denmark and Iceland in the areas of ostomy,..
About Coloplast
In 1954, Elise Sørensen, a Danish nurse, faced a challenge that would change the lives of millions. Her sister, Thora, had undergone ostomy surgery and struggled with the available solutions. Driven by a desire to help, Elise envisioned the world's first adhesive ostomy bag. This innovation was brought to life by Aage Louis-Hansen, a civil engineer, and his wife, Johanne Louis-Hansen, who founded Coloplast in 1957 to manufacture this groundbreaking product.
Coloplast's journey from a small Danish startup to a global leader in medical devices is marked by innovation and empathy. The company's commitment to improving the quality of life for people with intimate healthcare needs has driven its expansion into new markets and product lines, including continence care, wound care, and skin health.
In 1983, Coloplast went public, marking a significant milestone in its growth trajectory. This move not only provided the capital needed for further expansion but also solidified its reputation as a trusted name in healthcare. Over the years, Coloplast has continued to innovate, developing new products and solutions that address the evolving needs of patients and healthcare professionals.
Today, Coloplast operates in over 40 countries, serving millions of users worldwide. Its success is a testament to the power of addressing real-world problems with practical solutions, a philosophy that has guided the company since its inception. Coloplast's story is one of compassion, innovation, and a relentless pursuit of excellence in healthcare.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1954
- Headquarters
- Denmark
- Listing
- IPO 2000
- Employees
- 10,066
- Open positions
- None listed
- Dealroom signal
- 44.9/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech
- Client focus
- b2c
- Investment activity
- 3 companies, latest Jul 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| IPO✓Exit | Jan 2000 | $0 | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Coloplast is 13K monthly website visits, down 35% over the last three months. Coloplast's team grew 33.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
KerecisÍsafjörður, IcelandDevelops, manufactures, and markets implants and repair materials for the human body from omega3 rich fish skin
$1.3Bvaluation
Atos MedicalBridlington, United KingdomGiving a voice to people who breathe through a stoma
$2.5Bvaluation
Comfort MedicalCoral Springs, United StatesAn extensive selection of name brand catheter and ostomy supplies to thousands of customers nationwide
$160Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Danske Bank
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Coloplast on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Coloplast’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







